(Washington, D.C., January 14, 2021) In 2020, Global Liver Institute (GLI), whose mission is to improve the lives of individuals and families impacted by liver disease through promoting...
(Washington, D.C., January 8, 2021) In 2020, Global Liver Institute (GLI) observed increases in the prevalence of liver diseases and mortality associated with it. These developments are...
(Washington, D.C., January 6, 2021) Global Liver Institute (GLI) applauds the leadership of Congresswoman Nydia Velázquez (D-NY) in introducing the COVID-19 Prevention and...
Happy New Year! As we reassess, reset, and re-engage in our work with and for people, families, and communities around the world at-risk for and living with liver conditions, I wanted to take a...
(Washington, D.C., December 18, 2020) – Today, Global Liver Institute (GLI) and the GLI NASH Council released the U.S. NASH Action Plan to comprehensively address nonalcoholic steatohepatitis...
Give a gift to GLI This has been a year of tremendous turmoil across the world, but it has also been a time of tremendous generosity, fortitude, and empathy. Throughout the pandemic and the...
The U.S. Department of Health and Human Services (HHS) has proposed organ procurement organization (OPO) reforms that will help thousands more patients access organ transplants. We have a...
Responses to misleading claims from the Association of Organ Procurement Organizations (AOPO) Summary: HHS has proposed OPO reforms that will help thousands more patients access organ transplants....
Here at GLI, we understand the vital role that caregivers/carepartners play in the lives of liver patients. Caregivers are more important than ever during the COVID-19 pandemic, but it has brought...
Although all humans appear susceptible to infection by the COVID-19 virus, some communities and some racial and ethnic groups are infected, experience greater illness, and are hospitalized at rates...
Recent News
Global Liver Institute Supports the U.S. House Ways and Means Committee's Markup of Legislation to Expand Obesity Care CoverageGlobal Liver Institute strongly supports the amendment to be considered in the House Ways and Means Committee today to extend coverage for...
Policy, Prevention, and Progress: Fatty Liver & Obesity Dr. Kelly Brownell, Dean Emeritus of the Sanford School of Public Policy at Duke University, has over 35 years of experience studying food systems and obesity. After initially focusing on obesity treatments,...
Perils of AI in Healthcare Donna Cryer, JD, and Deborah SobelAs the founder and CEO of Global Liver Institute (GLI), and a liver transplant patient myself, I know it is imperative to connect the dots between real-world experiences of patients and policy solutions....
From Awareness to Action on Global Fatty Liver Day Global Liver Institute Unites the Field in Times of Name Changes and New Treatments(Washington, DC - June 13, 2024) – Today marks the seventh annual Global Fatty Liver Day (formerly International NASH Day), led by...
GLI Celebrates with PBC Patient Community upon U.S. FDA’s Approval of Second-Line Treatment(Washington, D.C. June 10, 2024) – Global Liver Institute (GLI) celebrates the decision of the U.S. Food and Drug Administration (FDA) to provide accelerated approval to...
